FSGS

This study tests a drug called atacicept in 200 adults and teens with autoimmune kidney diseases like IgAN and FSGS. The goal is to see if it safely reduces protein in the urine and helps preserve kidney function. Participants must already be on standard treatments and weigh at l…

This study tests an experimental drug, DMX-200, in about 286 people with a rare kidney disease called FSGS. The drug aims to reduce protein in the urine and slow down kidney damage. Participants must be 12 to 80 years old and already taking a standard blood pressure medication (A…

This study helps people with certain kidney diseases (like nephrotic syndrome and FSGS) find clinical trials that might be a good fit for their specific condition. Researchers use advanced molecular testing to match each person's unique disease profile to targeted therapies being…

This study is gathering information and biological samples from 300 people with FSGS or MCD who have had or will have a kidney transplant. Researchers want to learn why the disease sometimes comes back after transplant, which can lead to graft loss. The goal is to create a shared…

This early-stage study tests the safety of a new oral drug called SK-09 in 72 healthy adults aged 18 to 55. It is the first time this drug is given to humans, and it aims to find a safe dose for future studies in patients with kidney diseases like FSGS and MCD. Participants recei…

This study interviews 150 children, adults, and parents about their experiences with swelling caused by Nephrotic Syndrome. Researchers will use the information to create a survey that helps test new medications. No treatment is given; the goal is to better understand symptoms.